115 related articles for article (PubMed ID: 7505198)
1. Comparison of two antibody-based methods for elimination of breast cancer cells from human bone marrow.
Myklebust AT; Godal A; Juell S; Pharo A; Fodstad O
Cancer Res; 1994 Jan; 54(1):209-14. PubMed ID: 7505198
[TBL] [Abstract][Full Text] [Related]
2. Eradication of small cell lung cancer cells from human bone marrow with immunotoxins.
Myklebust AT; Godal A; Pharo A; Juell S; Fodstad O
Cancer Res; 1993 Aug; 53(16):3784-8. PubMed ID: 8393381
[TBL] [Abstract][Full Text] [Related]
3. Reactivity of anti-CD15 monoclonal antibody PM-81 with breast cancer and elimination of breast cancer cells from human bone marrow by PM-81 and immunomagnetic beads.
Vredenburgh JJ; Simpson W; Memoli VA; Ball ED
Cancer Res; 1991 May; 51(9):2451-5. PubMed ID: 1673088
[TBL] [Abstract][Full Text] [Related]
4. Elimination of malignant clonogenic breast cancer cells from human bone marrow.
Anderson IC; Shpall EJ; Leslie DS; Nustad K; Ugelstad J; Peters WP; Bast RC
Cancer Res; 1989 Aug; 49(16):4659-64. PubMed ID: 2663144
[TBL] [Abstract][Full Text] [Related]
5. Elimination of clonogenic tumor cells from human bone marrow using a combination of monoclonal antibody:ricin A chain conjugates.
Bregni M; De Fabritiis P; Raso V; Greenberger J; Lipton J; Nadler L; Rothstein L; Ritz J; Bast RC
Cancer Res; 1986 Mar; 46(3):1208-13. PubMed ID: 3510720
[TBL] [Abstract][Full Text] [Related]
6. Elimination of B-lymphoma cells from human bone marrow: model experiments using monodisperse magnetic particles coated with primary monoclonal antibodies.
Kvalheim G; Fodstad O; Pihl A; Nustad K; Pharo A; Ugelstad J; Funderud S
Cancer Res; 1987 Feb; 47(3):846-51. PubMed ID: 3492268
[TBL] [Abstract][Full Text] [Related]
7. Elimination of malignant tumor cells from human bone marrow using monoclonal antibodies and immunomagnetic beads.
Wang SY; Makl KL; Chen LY; Tzeng CH; Hu CP; Chang C
Anticancer Res; 1993; 13(6A):2281-5. PubMed ID: 8297147
[TBL] [Abstract][Full Text] [Related]
8. An effective immunomagnetic method for bone marrow purging in T cell malignancies.
Wang MY; Kvalheim G; Kvaløy S; Beiske K; Jakobsen E; Wijdenes J; Pihl A; Fodstad O
Bone Marrow Transplant; 1992 May; 9(5):319-23. PubMed ID: 1617315
[TBL] [Abstract][Full Text] [Related]
9. The efficiency of tumor cell purging using immunomagnetic CD34+ cell separation systems.
Roots-Weiss A; Papadimitriou C; Serve H; Hoppe B; Koenigsmann M; Reufi B; Oberberg D; Thiel E; Berdel WE
Bone Marrow Transplant; 1997 Jun; 19(12):1239-46. PubMed ID: 9208119
[TBL] [Abstract][Full Text] [Related]
10. Immunological and pharmacological removal of small cell lung cancer cells from bone marrow autografts.
Humblet Y; Feyens AM; Sekhavat M; Agaliotis D; Canon JL; Symann ML
Cancer Res; 1989 Sep; 49(18):5058-61. PubMed ID: 2548708
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of monoclonal antibody DF3 conjugated with ricin as a specific immunotoxin for in vitro purging of human bone marrow.
Tondini C; Pap SA; Hayes DF; Elias AD; Kufe DW
Cancer Res; 1990 Feb; 50(4):1170-5. PubMed ID: 2404589
[TBL] [Abstract][Full Text] [Related]
12. Purging of small cell lung cancer-contaminated bone marrow by monoclonal antibodies and magnetic beads.
Elias AD; Pap SA; Bernal SD
Prog Clin Biol Res; 1990; 333():263-75. PubMed ID: 2155434
[TBL] [Abstract][Full Text] [Related]
13. Removal of breast cancer cells from bone marrow by in vitro purging with ether lipids and cryopreservation.
Dietzfelbinger HF; Kühn D; Zafferani M; Hanauske AR; Rastetter JW; Berdel WE
Cancer Res; 1993 Aug; 53(16):3747-51. PubMed ID: 8339286
[TBL] [Abstract][Full Text] [Related]
14. Elimination of small cell carcinoma of the lung from human bone marrow by monoclonal antibodies and immunomagnetic beads.
Vredenburgh JJ; Ball ED
Cancer Res; 1990 Nov; 50(22):7216-20. PubMed ID: 2171759
[TBL] [Abstract][Full Text] [Related]
15. Long-term culture of autologous bone marrow for marrow reconstitution following high-dose chemotherapy. Purging with tumor surface antigen directed human-human monoclonal antibody.
Alonso K; Medenica R; Morehead G
Prog Clin Biol Res; 1994; 389():111-8. PubMed ID: 7700892
[No Abstract] [Full Text] [Related]
16. Efficient and nontoxic adenoviral purging method for autologous transplantation in breast cancer patients.
Lillo R; Ramírez M; Alvarez A; Santos S; García-Castro J; Fernández de Velasco J; Avilés MJ; Gómez-Pineda A; Díez JL; Balas A; Vicario JL; Bueren JA; García-Sánchez F
Cancer Res; 2002 Sep; 62(17):5013-8. PubMed ID: 12208755
[TBL] [Abstract][Full Text] [Related]
17. Combination of magnetic and chemocytotoxic cancer cell depletion for autologous bone marrow transplantation.
Morecki S; Slavin S
Isr J Med Sci; 1988; 24(9-10):488-93. PubMed ID: 3060442
[TBL] [Abstract][Full Text] [Related]
18. Use of immunotoxins in combination to inhibit clonogenic growth of human breast carcinoma cells.
Yu YH; Crews JR; Cooper K; Ramakrishnan S; Houston LL; Leslie DS; George SL; Lidor Y; Boyer CM; Ring DB
Cancer Res; 1990 Jun; 50(11):3231-8. PubMed ID: 2334918
[TBL] [Abstract][Full Text] [Related]
19. Purging of epithelial tumor cells from peripheral blood stem cells by means of the bispecific antibody BIS-1.
Schröder CP; Kroesen BJ; de Leij LF; de Vries EG
Clin Cancer Res; 2000 Jun; 6(6):2521-7. PubMed ID: 10873108
[TBL] [Abstract][Full Text] [Related]
20. Elimination of clonogenic T-leukemic cells from human bone marrow using anti-Mr 65,000 protein immunotoxins.
Stong RC; Youle RJ; Vallera DA
Cancer Res; 1984 Jul; 44(7):3000-6. PubMed ID: 6372999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]